Evaluating the clinical utility and strategy of whole-exome sequencing testing for fetuses with increased nuchal translucency

This publication has 32 references indexed in Scilit:

• The clinical impact of the first‐trimester nuchal translucency between the 95th–99th percentiles
  Prenatal Diagnosis, 2023
• Diagnostic yield of next‐generation sequencing in fetuses with isolated increased nuchal translucency: systematic review and meta‐analysis
  Ultrasound in Obstetrics & Gynecology, 2021
• Exome sequencing improves genetic diagnosis of fetal increased nuchal translucency
  Prenatal Diagnosis, 2020
• Is there still a role for nuchal translucency measurement in the changing paradigm of first trimester screening?
  Prenatal Diagnosis, 2019
• Microarray and RASopathy‐disorder testing in fetuses with increased nuchal translucency
  Ultrasound in Obstetrics & Gynecology, 2019
• Whole exome sequencing as a diagnostic adjunct to clinical testing in fetuses with structural abnormalities
  Ultrasound in Obstetrics & Gynecology, 2017
• Cut‐off value of nuchal translucency as indication for chromosomal microarray analysis
  Ultrasound in Obstetrics & Gynecology, 2017
• The performance of an intermediate 16th‐week ultrasound scan for the follow‐up of euploid fetuses with increased nuchal translucency
  Prenatal Diagnosis, 2015
• Genomic microarray in fetuses with increased nuchal translucency and normal karyotype: a systematic review and meta‐analysis
  Ultrasound in Obstetrics & Gynecology, 2015
• Nuchal translucency and major congenital heart defects in fetuses with normal karyotype: a meta‐analysis
  Ultrasound in Obstetrics & Gynecology, 2013